Optiver Holding
AVXL icon

Optiver Holding’s Anavex Life Sciences AVXL Stock Holding History

Optiver Holding’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2K Buy
+6,652
New +$19.7K ﹤0.01% 1580
2025
Q4 		– Sell
-204
Closed -$1.82K – 2501
2025
Q3 		$1.82K Buy
+204
New +$2.07K ﹤0.01% 2411

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Optiver Holding's AVXL Position: Q2 2026 in Review

Optiver Holding opened a new position in Anavex Life Sciences (AVXL) in Q2 2026: 6,652 shares worth $17.2K. The stake represents ﹤0.01% of the portfolio and ranks #1580 among its holdings. This is a return to the name: Optiver Holding previously reported a position in AVXL as recently as Q3 2025.

Optiver Holding first reported a position in AVXL in Q3 2025 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Optiver Holding held 6,652 shares of Anavex Life Sciences worth $17.2K as of Q2 2026.
  • Anavex Life Sciences was a new Optiver Holding position in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1580 holding.
  • Optiver Holding first reported a position in Anavex Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.